Browse by article | Browse by volume |
Heroin Addiction and Related Clinical Problems: 2017, 19, N2 (pages: 59 - 68)
Phelan J.
Summary: Background: The use of buprenorphine for the treatment of opioid use disorders has increased significantly in the past 10 years indicating a rapidly changing course of treatment. Methods: In order to see what extent psychosocial domains have been measured at baseline and at ending points with patients taking buprenorphine, an overview of the literature was conducted. Results: The reports that were eligible for review were promising as they yielded evidence of improved psychosocial outcomes including psychological, family, social, legal, employment, environmental ones in relation to buprenorphine treatment. Reductions in sexual risk behaviors were also found in some reports. The majority of participants were also engaged in some form of psychosocial intervention combined with buprenorphine treatment. Conclusions: Although more research is needed, the data available implies more attention be given to outcomes of treatment and the psychosocial needs of patients diagnosed with opioid use disorder/dependence, making a case for increased access to care.
EUROPAD - European Opiate Addiction Treatment Association Brussels, Belgium, EU P. IVA 01681650469 – Codice Fiscale 94002580465 Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org |